Kenneth C. Anderson

Researcher Next ID · RN-001243

Researcher · Medicine

Cambridge, United States

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Multiple Myeloma Research and Treatments

Protein Degradation and Inhibitors

Peptidase Inhibition and Analysis

Ubiquitin and proteasome pathways

Chronic Lymphocytic Leukemia Research

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30206-6
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70442-5
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Cell · 2011 · https://doi.org/10.1016/j.cell.2011.08.017
International uniform response criteria for multiple myeloma
Leukemia · 2006 · https://doi.org/10.1038/sj.leu.2404284
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa030288

No projects listed.